B cell depleting agents can cause altered immune responses to COVID-19 vaccines, suggests study

By | July 2, 2021
A new preprint, available on the medRxiv* server, describes altered responses to the use of the highly effective messenger RNA (mRNA) vaccines from Pfizer/BioNTech and Moderna in patients with multiple sclerosis on anti-CD20 (MS-aCD20) monotherapy.